Altria Group, Inc. (MO)
Dividend Harvesting Portfolio Week 254: $25,400 Allocated, $2,720.76 In Projected Dividends
The Dividend Harvesting Portfolio, built with $100/week, now yields 8.04% and has returned 33.22% on invested capital. I am bullish on energy, real estate, and undervalued dividend stocks like OKE and VZ, expecting them to outperform in a lower-rate environment. Portfolio diversification across 41 positions and asset classes has driven consistent income growth, with forward annualized dividend income reaching $2,720.76.
Altria (MO) Advances While Market Declines: Some Information for Investors
Altria (MO) closed the most recent trading day at $60.15, moving +2.75% from the previous trading session.
Altria Stock Falls 8.2% in Three Months: What Should Investors Do?
Altria Group, Inc. ( MO ), a prominent name in the tobacco and vaping space, has faced notable pressure in recent months, with its shares declining 8.2% over the past three months. This drop stands in stark contrast to the broader market's strength, as the Zacks Tobacco industry advanced 1.7%, the Zacks Consumer Staples sector gained 1.2% and the S&P 500 rallied 6.4% over the same period.
Altria (MO) Surpasses Market Returns: Some Facts Worth Knowing
Altria (MO) closed the most recent trading day at $58.54, moving +1.76% from the previous trading session.
Altria's Discount Strategy: Is Basic Brand a Smart Move for It?
MO shifts its cigarette mix toward lower-priced options as consumers become more price-conscious, helping cushion volume pressure in a challenging market.
3 Oversold Stocks Ready to Rebound in 2026
The S&P 500 booked its third consecutive gain of over 15% in 2025, but it wasn't a banner year for everyone. Some of the market's previous objects of affection treaded water in 2025, especially following the tariff re-rating in April.
Altria: High Yield Is Underwritten By Cigarettes, Not Vapes And Oral Pouches
Altria remains heavily reliant on traditional cigarettes, with smoke-free products contributing minimally to revenues and earnings. I expect combustible dominance to continue going forward, due to litigation resulting in a sales ban for Altria's vapes, as well as the exploding market for illegally imported flavored products. Oral pouches (on!) also face significant competition from ZYNs (produced by Philip Morris).
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Altria: Mispriced And Oversold (Technical Analysis)
Altria Group (MO) presents a strong contrarian opportunity both for swing traders and long-term investors. In the near term, the stock trades near key support at ~$55 with technical indicators signaling a potential rebound. Fundamentally, MO's current P/E of ~10x reflects market pessimism over topline declines, but exceptional profitability and pricing power remain underappreciated.
Is Altria's Smoke-Free Push Enough to Stabilize Growth Over Time?
MO is moving beyond cigarettes as volumes fall, focusing on oral nicotine, e-vapor and heated tobacco to support growth.
Altria: A Turnaround Stock For 2026 (Rating Upgrade)
Altria presents a compelling turnaround opportunity for 2026, driven by leadership transition, regulatory wins, and an expanded $2.0B stock buyback program. MO is on track to pay out ~76% of its adjusted EPS in 2026, which leaves room for new category investments as well as a higher dividend. Regulatory approval for six new on!-branded nicotine pouches and ongoing pivot to smoke-free products support future growth despite secular declines in combustibles.
Altria Nicotine Pouch Volumes Surge: Is Helix the Real Profit Driver?
MO's Helix Innovations is lifting oral tobacco results as nicotine pouch volumes climb, prices rise, and margins expand despite declines in other categories.
